Novel drug delivery strategies in veterinary medicine

Irish Veterinary Journal

Volumn 56, Issue 6, 2003, Pages 310-316

  Brayden, David J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Controlled release; Nasal drug delivery; Oral drug delivery; Subcutaneous implants; Transdermal patches

Indexed keywords

PEPTIDE;

BIOTECHNOLOGY; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG RESEARCH; GENE DELIVERY SYSTEM; LIVESTOCK; NONHUMAN; REVIEW; TRANSDERMAL PATCH; VETERINARY MEDICINE;

EID: 0038383083     PISSN: 03680762     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Alsenz, J., Russell-Jones, G.J., Westwood, S., Levet-Trafit, B. and de Smidt, P.C. (2000). Oral absorption of peptides through the cobalamin (vitamin B12) pathway in the rat intestine. Pharmaceutical Research 17: 825-832.
2. Baeyens, V., Felt-Baeyens, O., Rougier, S., Pheulpin, S., Boisrame, B. and Gurny, R. (2002). Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI®) for the treatment of external ocular infections in dogs. Journal of Controlled Release 13: 163-168.
3. Baichwal, A. and Neville, D.A. (2002). Adding value to product's life-cycle management: product enhancement through drug delivery systems. Drug Delivery Technology, http://www.drugdeliverytech.com/cgi-bin/articles.cgi?idArticle=8.
4. Barry, B.W. (2001). Novel mechanisms and devices to enable successful transdermal drug delivery. European Journal of Pharmaceutical Science 14: 101-114.
5. Baughman, R.A., Capoor, S.C., Agarwal, R., Kisicki, J., Catella-Lawson, F. and FitzGerald, G.A. (1998). Oral delivery of anticoagulant doses of heparin. Circulation 98: 1610-1615.
6. Brayden, D.J. and Baird, A.W. (2001). Microparticle approaches to stimulate mucosal immunisation. Microbes and Infection 3: 867-876.
7. Brayden, D.J. and O'Mahony, D.J. (1998). Novel oral drug delivery gateways for biotechnology products: polypeptides and vaccines. Pharmaceutical Science and Technology Today 1: 291-299.
8. Burns, P.J. (1999). Enhanced reproductive management of domesticated livestock using biodegradable controlled release drug delivery. Proceedings of the International Symposium of Controlled Release of Bioactive Materials 26: 64-65.
9. Cardinal, J.R. and Witchey-Lakshmanan, L.C. (1992). Drug delivery in veterinary medicine. In: Treatise on Controlled Drug Delivery. Edited by A. Kydonieus. pp 465-489. New York: Marcel Deckker.
10. Chien, Y.W. (1992). Concepts and system design for the rate controlled drug delivery. In: Novel Drug Delivery. Second edition. Edited by Y.W. Chien. pp 1-42. New York: Marcel Deckker.
11. Delgado, A., Lavelle, E.C., Hartshorne, M. and Davis, S.S. (1999). PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems. Vaccine 17: 2927-2938.
12. Dryden, M.W., Denenberg, T.M. and Bunch, S. (2000). Control of fleas on naturally infested dogs and cats and in private residences with topical spot applications of fipronil or imidacloprid. Veterinary Parasitology 93: 69-75.
13. Eldridge, J.H., Meulbroek, J.A., Staas, J.K., Tice, T.R. and Gilley, R.M. (1989). Vaccine-containing biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response. Advances in Experimental Medical Biology 251: 191-202.
14. El-Gibaly, I. (2002). Oral delayed-release system based on Zn-pectinate gel (ZPG) microparticles as an alternative carrier to calcimn pectinate beads for colonic drug delivery. International Journal of Pharmaceutics 232: 199-211.
15. Ellis, J.A., Haines, D.M., West, K.H., Burr, J.H., Dayton, A., Townsend, H.G., Kanara, E.W., Konoby, C., Crichlow, A., Martin, K. and Headrick, G. (2001). Effect of vaccination on experimental infection with Bordetella bronchiseptica in dogs. Journal of the American Veterinary Medical Association 218: 367-375.
16. Fischetti, F. (2001). Working knowledge: flea treatments; killer drops. Scientific American 285 (September): 84-85.
17. Gluck, R. (2001). Pre-clinical and clinical investigation of the safety of a novel adjuvant for intranasal immunization. Vaccine 20, Suppl. 1: S42-44.
18. Gruet, P., Caillard, C., Boisrame, B., Duffaut, D., Grimoud, A.M. and Camy, G. (1995). Use of an oral antiseptic bioadhesive tablet in dogs. Journal of Veterinary Dentistry 12: 87-91.
19. Gruet, P., Maincent, P., Berthelat, X. and Kalsatos, V. (2001). Bovine mastitis and intramammary drug delivery: review and perspectives. Advanced Drug Delivery Reviews 50: 245-259.
20. Han, H.-K. and Amidon, G.L. (2000). Targeted prodrug design to optimize drug delivery. American Association of Pharmaceutical Scientists PharmSci 2: Article 6. http://www.aapspharmsci.org/ps0201/ps020106/ps020106.pdf.
21. Hussain, A.A. (1998). Intranasal drug delivery. Advanced Drug Delivery Reviews 29: 39-49.
22. Illum, L., Watts, P., Fisher, A.N., Hinchcliffe, M., Norbury, H., Jabbal-Gill, I., Nankervis, R. and Davis, S.S. (2002). Intranasal delivery of morphine. Journal of Pharmacology and Experimental Therapeutics 301: 391-400.
23. Katsung, B.G. (2001). Treatment of glaucoma. In: Basic and Clinical Pharmacology. Eighth edition. p151. New York: McGraw-Hill.
24. Kyles, A.E., Papich, M. and Hardie, E. (1996). Disposition of transdermally-administered fentanyl in dogs. American Journal of Veterinary Research 57: 715-719.
25. Laffont, C.M., Alvinerie, M., Bousquet-Malon, A. and Toutain, P.L. (2001). Licking behaviour and environmental contamination arising from pour-on ivermectin for cattle. International Journal of Parasitology 31: 1687-1692.
26. Lambkin, I. and Pinella, C. (2002). Targeting approaches to oral drug delivery. Expert Opinion in Biological Therapeutics 2: 67-73.
27. Lloyd, J.E., Kumar, R., Grubbs, M.A., Waggoner, J.W., Norelius, E.E., Smith, L.L., Brake, A.C., Skogerboe, T.L. and Shostrom, V.K. (2001). Persistent efficacy of doramectin topical solution against induced infestations of Bovicola bovis and Solenopotes capillatus. Veterinary Parasitology 13: 235-241.
28. Lundin, P.D., Bojrup, M., Ljusberg-Wahren, H., Westrom, B.R. and Lundin, S. (1997). Enhancing effects of monohexanoin and two other medium chain glyceride vehicles on intestinal absorption of desmopressin (dDAVP). Journal of Pharmacology and Experimental Therapeutics 282: 585-590.
29. Modi, P., Mihic, M. and Lewin, A. (2002). The evolving role of oral insulin in the treatment of diabetes using a novel RapidMist™ system. Diabetes Metabolism Research Reviews 18: Suppl. 1: S38-S42.
30. Muijsers, R.B. and Wagstaff, A.J. (2001). Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control. Drugs 61: 2289-2307.
31. Pontiroli, A.E. (1998). Peptide hormones: review of current and emerging uses by nasal delivery. Advanced Drug Delivery Reviews 29: 81-87.
32. Rathbone, M.J., Macmillan, K.L., Jochle, W., Boland, M.P. and Inskeep, E.K. (1998). Controlled-release products for the control of the estrus cycle in cattle, sheep, goats, deer, pigs and horses. Critical Reviews in Therapeutic Drug Carrier Systems 15: 285-379.
33. Rathbone, M.J. and Martinez, M.N. (2002). Modified release drug delivery in veterinary medicine. Drug Discovery Today 7: 823-829.
34. Riviere, J.E. and Papich, M.G. (2001). Potential and problems of developing transdermal patches for veterinary applications. Advanced Drug Delivery Reviews 50: 175-203.
35. Rothen-Weinhold, A., Gurny, R. and Dahn, M. (2000). Formulation and technology aspects of controlled drug delivery in animals. Pharmaceutical Science and Technology Today 3: 222-231.
36. Sarasola, P., Jernigan, A.D., Walker, D.K., Castledine, J., Smith, D.G. and Rowan, T.G. (2002). Pharmacokinetics of selamectin following intravenous, oral and topical administration in cats and dogs. Journal of Veterinary Pharmacology and Therapeutics 25: 265-272.
37. Townsend, H.G., Penner, S.J., Watts, T.C., Cook, A., Bogdan, J., Haines, D.M., Griffin, S., Chambers, T., Holland, R.E., Whitaker-Dowling, P., Youngner, J.S. and Sebring, R.W. (2001). Efficacy of a cold adapted, intranasal, equine influenza vaccine: challenge trials. Equine Veterinary Journal 7: 637-643.
38. Van der Lubben, I.M., Verhoef, J.C., Borchard, G. and Junginger, H.E. (2001). Chitosan for mucosal vaccination. Advanced Drug Delivery Reviews 52: 139-144.
39. Witchey-Lakshmanan, L.C. (1999). Long-acting control of ectoparasites: a review of collar technologies for companion animals. Advanced Drug Delivery Reviews 38: 113-122.
40. Wood-McKinsey Report (2001). Communicated by T.P. Foster. Principles of veterinary release dosage forms. AAPS Workshop on Collaboration in the Research and Development of Veterinary Pharmaceuticals, St Charles, Illinois (May 6-8, 2002).
41. Zakhartchouk, A.N., Pyne, C., Mutwiri, G.K., Papp, Z., Baca-Estrada, M.E., Griebal, P., Babiuk, L.A. and Tikoo, S.K. (1999). Mucosal immunization of calves with recombinant bovine adenovirus 3: induction of protective immunity to bovine herpesvirus-1. Journal of General Virology 80: 1263-1269